Please Note: This trial is no longer enrolling new participants
Study M23-324: A First-in-Human Study of ABBV-525 (MALT1 Inhibitor) in B-Cell Malignancies
Protocol No. | CTO-M23-324 | Scope | National |
---|---|---|---|
Principal Investigator | Rita Assi | Treatment Type | Treatment |
Age Group | Adult | Phase | Phase I |